Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of cytokines levels with epidermal growth factor receptor mutation in lung cancer patients.

Journal of cancer research and therapeutics - 1 Jan 2000

Gaur Priyanka, Bhattacharya Sandeep, Kant Surya, Kushwaha R A S, Singh Gaurav, Pandey Sarika

Abstract excerpt

BACKGROUND: Lung cancer is one of the most frequent types of cancer and the leading cause of cancer-related deaths. Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase (TK) being highly expressed in lung cancers. Activation of EGFR through oncogenic mutations leads to upregulation of gene expression that may heighten the inflammatory response in certain situations. EGFR acts as a key regulator...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 32930123
DOI: 10.4103/jcrt.JCRT_632_18

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of cytokines levels with epidermal growth factor receptor mutation in lung cancer patients.PMID 32930123Read ↗

Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients.Semantic proximity Read ↗

EGFR Mutation Detection and Its Association With Clinicopathological Characters of Lung Cancer PatientsSemantic proximity Read ↗

Shaping the battlefield: EGFR and KRAS tumor mutations' role on the immune microenvironment and immunotherapy responses in lung cancer.Semantic proximity Read ↗

The relationship between EGFR mutation status and clinic-pathologic features in pulmonary adenocarcinoma.Semantic proximity Read ↗

Association of epidermal growth factor receptor (EGFR) gene polymorphism with lung cancer risk: a systematic review.Semantic proximity Read ↗

Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.Semantic proximity Read ↗

Pulmonary Inflammation and KRAS Mutation in Lung Cancer.Semantic proximity Read ↗

A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors.Semantic proximity Read ↗

[Correlation between Immune Microenvironment Features and EGFR Mutation Status in Lung Adenocarcinoma].Semantic proximity Read ↗

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury.Semantic proximity Read ↗

[KRAS status versus EGFR status in lung cancer therapy].Semantic proximity Read ↗

Relationship between epidermal growth factor receptor mutations and CT features in patients with lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.